Drug Shortage Report for APO-WARFARIN

Last updated on 2020-06-08 History
Report ID 102671
Drug Identification Number 02242926
Brand name APO-WARFARIN
Common or Proper name WARFARIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) WARFARIN SODIUM
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code B01AA
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-06
Estimated end date 2020-06-12
Actual end date 2020-06-05
Shortage status Resolved
Updated date 2020-06-08
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-08 English Compare
v2 2020-01-08 French Compare
v3 2020-01-14 English Compare
v4 2020-01-14 French Compare
v5 2020-02-18 English Compare
v6 2020-02-18 French Compare
v7 2020-03-03 English Compare
v8 2020-03-03 French Compare
v9 2020-05-27 English Compare
v10 2020-05-27 French Compare
v11 2020-06-08 English Compare
v12 2020-06-08 French Compare